Catalyst Pharmaceuticals, Inc.

GOLDMAN SACHS GROUP INC CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

979,543

Value ($000)

22,863

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	22,863	0.0%	979,543	12/31/2025
2025 Q3	11/14/2025	19,843	0.0%	1,007,235	9/30/2025
2025 Q2	8/14/2025	52,333	0.0%	2,411,660	6/30/2025
2025 Q1	6/27/2025	76,035	0.0%	3,135,473	3/31/2025
2024 Q4	2/11/2025	58,486	0.0%	2,802,373	12/31/2024
2024 Q3	11/14/2024	29,268	0.0%	1,472,253	9/30/2024
2024 Q2	8/13/2024	16,855	0.0%	1,088,131	6/30/2024
2024 Q1	5/15/2024	15,960	0.0%	1,001,281	3/31/2024
2023 Q4	5/14/2024	16,111	0.0%	958,413	12/31/2023
2023 Q3	5/15/2024	11,320	0.0%	968,319	9/30/2023
2023 Q2	5/14/2024	16,807	0.0%	1,250,528	6/30/2023
2023 Q1	5/14/2024	18,847	0.0%	1,136,737	3/31/2023
2022 Q4	5/14/2024	14,210	0.0%	763,963	12/31/2022
2022 Q3	5/14/2024	9,240	0.0%	720,126	9/30/2022
2022 Q2	5/14/2024	13,394	0.0%	1,910,664	6/30/2022
2022 Q1	5/16/2022	9,147	0.0%	1,103,361	3/31/2022
2021 Q4	2/17/2022	4,887	0.0%	721,926	12/31/2021
2021 Q3	1/20/2022	3,789	0.0%	714,857	9/30/2021
2021 Q2	8/13/2021	6,142	0.0%	1,068,147	6/30/2021
2021 Q1	5/17/2021	6,556	0.0%	1,421,993	3/31/2021
2020 Q4	2/12/2021	10,763	0.0%	3,222,590	12/31/2020
2020 Q3	11/13/2020	7,518	0.0%	2,531,488	9/30/2020
2020 Q2	8/12/2020	9,564	0.0%	2,070,240	6/30/2020
2020 Q1	5/15/2020	7,563	0.0%	1,964,464	3/31/2020
2019 Q4	2/14/2020	7,226	0.0%	1,926,995	12/31/2019